Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from authoritative sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Major drugmaker loses $27 billion in market value after failed trial

MarketWatch

BusinessMarketWatch·Jul 9, 2026·1 min read

Major drugmaker loses $27 billion in market value after failed trial

Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.

View original source — MarketWatch ↗

ShareShare on X Share on Facebook

Related stories

Reporters’ Social Media Challenge Lands With a Thud

BusinessJul 9, 2026 · 1 min

Reporters’ Social Media Challenge Lands With a Thud

My retirement savings will suffer if I delay Social Security. How do I choose between the two?

BusinessJul 9, 2026 · 1 min

My retirement savings will suffer if I delay Social Security. How do I choose between the two?

10 stocks for momentum traders to consider buying — and 10 to avoid or sell short

BusinessJul 9, 2026 · 1 min

10 stocks for momentum traders to consider buying — and 10 to avoid or sell short

Nigeria: Senate Approves Customs' 2026 Budget, Backs N11.074trn Revenue Target

BusinessJul 9, 2026 · 1 min

Nigeria: Senate Approves Customs' 2026 Budget, Backs N11.074trn Revenue Target